Edward B. Garon, MD, MS - Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - June 21, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Amir T. Fathi, MD - The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care
The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - June 21, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Anjali Saqi, MD, MBA and Geoffrey R. Oxnard, MD - Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - June 21, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Neal D. Shore, MD, FACS - Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care
Go online to PeerView.com/XNW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The therapeutic landscape of advanced urothelial carcinoma of the bladder has undergone significant transformation in the last 2 years, with the emergence of immune checkpoint inhibitors as an essential component of the treatment armamentarium. Extensive research is also focused on newer approaches, such as antibody-drug conjugates and FGFR inhibitors, against actionable targets on urothelial cancer cells. This rapid expansion in the field poses several challenges for urologists and other hea...
Source: Peerview CME/CE Video Podcast - Internal Medicine International - June 20, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Postponed (Date to be Determined) - ORWH Women's Health Seminar Series: Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is a randomized breast screening trial that will help researchers learn about the best ways to find breast cancer in women who have no symptoms. It compares two Food and Drug Administration-approved types of digital mammography: standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D). Researchers are doing this trial because they do not know if 3-D mammography is better than 2-D mammography for breast cancer screening.For more information go tohttps://orwh.od.nih.gov/Air date: 6/20/2019 1:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - June 18, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Elizabeth A. Mittendorf, MD, PhD - On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Go online to PeerView.com/ZEX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Tremendous advances have been made in the treatment of many other subtypes of breast cancer, but treatment of triple-negative breast cancer (TNBC) has remained challenging. However, recent developments suggest that we are on the brink of a new era in TNBC therapy that now brings the novel class of cancer immunotherapies to this population of patients. In this activity, based on a recent live satellite symposium held in Dallas, Texas during the 20th Annual Meeting of The American Society of Br...
Source: Peerview CME/CE Video Podcast - Internal Medicine International - June 18, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Integrative Omics Approaches to Identify New Therapeutic Cancer Targets
CCR Grand Rounds Kimberly Stegmaier, M.D., Professor of Pediatrics at Harvard Medical School and the Ted Williams Chair at Dana-Farber Cancer Institute, has advanced the application of genomics to drug and protein target discovery for pediatric cancers. She is the Vice Chair for Pediatric Oncology Research, co-director of the Pediatric Hematologic Malignancy Program and an attending physician providing clinical care in Pediatric Oncology at the Dana-Farber Cancer Institute and Boston Children ’ s Hospital. Dr. Stegmaier is also an Institute Member of the Broad Institute of Harvard and MIT. She has served as a Council...
Source: Videocast - All Events - June 17, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Pride in the Diversity of NIH
During this first awards program the Office of Equity, Diversity and Inclusion (EDI) will honor these NIH employees and fellows who are community members and allies nominated for their exemplary work helping to create safer spaces for SGM at the NIH. These awardees lead by example and encourage others to demonstrate unconditional compassion, leadership, and understanding towards members of the SGM community: Dr. Vivian Ota Wang, National Cancer Institute; Dr. Christopher Wheldon, National Cancer Institute; Adam Cornish, National Institute on Aging; Dr. Karen Parker, Sexual& Gender Minority Research Office, Tricia Coffe...
Source: Videocast - All Events - June 17, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Stephen V. Liu, MD - A New Era Has Begun in the Treatment of SCLC: Navigating Novel Therapeutic Options and Strategies for Improving Patient Outcomes
Go online to PeerView.com/UXH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in oncology discuss various treatment options for small cell lung cancer (SCLC), including the rationale for using new therapies, key clinical trial data, and methods for integrating novel therapies into routine practice or through clinical trial participation. Upon completion of this activity, participants will be able to: Describe the mechanisms of action and rationale for use of novel therapies for SCLC, including immune checkpoint inhibitors, PARP inhibitors, tra...
Source: Peerview CME/CE Video Podcast - Internal Medicine International - June 15, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

The Precancer Genome Atlas (PCGA) and Immune Interception
The Annual Advances in Cancer Prevention Lecture is sponsored by the Cancer Prevention Fellowship Program (CPFP) within the Division of Cancer Prevention (DCP) at NCI. It is also part of the course offerings of the annual NCI Summer Curriculum in Cancer Prevention, but is open to the entire NIH community and general public. This annual lecture addresses current challenges and/or approaches used by investigators to address gaps, advance science, and promote the application of successful strategies in the field of cancer prevention and control. This year's lecture will feature Scott M. Lippman, MD, Director of the...
Source: Videocast - All Events - June 12, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

CREAT2 Meeting 1
The CREAT2 meeting is held annually, and the goal is to convene and engage CSSI and CSR staff, staff within and outside NIH and NCI, and program/initiative stakeholders to share their ideas and programmatic advancements to stimulate new and exciting pilot projects and collaborations. This meeting will be supported by CSSI-CSR, whose mission is to create and uniquely implement exploratory programs focused on the development and integration of advanced technologies, trans-disciplinary approaches, infrastructures, and standards to accelerate the creation of publicly available, broadly accessible, multi-dimensional data, knowl...
Source: Videocast - All Events - June 11, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Gayle Jameson, MSN, ACNP-BC, AOCN - Clinical Advances in Pancreatic Cancer: The Oncology Nurse as a Leader and Advocate for Patients in a Changing Therapeutic Landscape
Oncology nurses are at the forefront of care for patients with pancreatic cancer, a much-feared disease whose management was for years characterized by modestly effective treatment options. The recent emergence of new cytotoxic platforms combined with rapid research on potent targeted therapies has made the role of the nurse as a caregiver and educator more important than ever, particularly because these new options differ greatly from conventional chemotherapy strategies. In this activity based on a recent live symposium held in Anaheim during the Oncology Nursing Society’s (ONS) 44th Annual Congress, expert nurse f...
Source: Peerview CME/CE Video Podcast - Internal Medicine International - June 11, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Chimeric Antigen Receptor T-cell Therapies for Hematological Malignancies
CCR Grand Rounds James Kochenderfer, M.D., is a tenure-track investigator in the Experimental Transplantation and Immunology Branch (ETIB) of the National Cancer Institute (NCI). For the past 12 years, Dr. Kochenderfer has focused on a full range of chimeric antigen receptor (CAR) research from designing and cons tructing new CARs to conducting clinical trials. Dr. Kochenderfer designed and constructed a novel anti-CD19 CAR and then participated in a clinical trial of this CAR. This clinical trial was the first to demonstrate antigen-specific activity of anti-CD19 CARs in humans. This work in anti-CD19 CAR T cells led to...
Source: Videocast - All Events - June 10, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC - An Oncology Nurse MasterClass on Oral Therapy in B-Cell Malignancies: Insights on Evidence, Practical Strategies, and the Nurse-Patient Partnership
Go online to PeerView.com/TTY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Recent developments in B-cell lymphoma have increased the availability of novel, orally administered therapies. Nurse professionals managing patients with B-cell cancers play a central role in caring for patients who are eligible for treatment with oral therapeutics, including BTK, PI3K, and BCL-2 inhibitors, and immunomodulating agents. In this activity, based on a recent live symposium held at the ONS 44th Annual Congress, an expert nurse faculty panel offers an in-depth look at the integra...
Source: Peerview CME/CE Video Podcast - Internal Medicine International - June 8, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Why don't we get more cancer: The importance of ECM Chromatin interactions in tissue-specificity and breast cancer
CCR Grand Rounds Mina J. Bissel, Ph.D., is a Distinguished Scientist, the highest rank bestowed at Lawrence Berkeley National Laboratory (LBNL) and serves as Senior Advisor to the Laboratory Director on Biology. She is also Faculty of four Graduate Groups in UC Berkeley: Comparative Biochemistry, Endocrinology, Molecular Toxicology, and Bioengineering (UCSF/UCB joint program). Having challenged several established paradigms, Bissell is a pioneer in breast cancer research and her body of work has provided much impetus for the current recognition of the significant role that extracellular matrix (ECM) signaling and microenvi...
Source: Videocast - All Events - June 3, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

John C. Byrd, MD - BTK Inhibition as an Anti-Cancer Strategy: Exploring a Model for Modern Targeted Therapy in Hematologic Malignancies and Beyond
Go online to PeerView.com/EQY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. This PeerView CME/CNE-certified activity—based on a live event conducted in a MasterClass format held in conjunction with the 2019 meeting of the AACR—discusses how Bruton tyrosine kinase (BTK) inhibitors effectively target aspects of B-cell receptor signaling and covers key evidence and clinical issues related to the use of BTK inhibitors in hematologic malignancies (including agent selection, potential combination regimens, and strategies for overcoming drug intolerance or resis...
Source: Peerview CME/CE Video Podcast - Internal Medicine International - May 22, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

CCR Grand Rounds - AAAS Martin and Rose Wachtel Cancer Research Award: Structure and Function of Mammalian SWI/SNF Complexes in Human Disease
Special CCR Grand Rounds 2019 AAAS Martin and Rose Wachtel Cancer Research Award and Lecture The Wachtel Cancer Research Award is presented to young cancer researchers who have made outstanding contributions to the cancer field. This is the seventh lecture for the AAAS Martin and Rose Wachtel Cancer Research Award sponsored by the American Association for the Advancement of Science (AAAS) and Science Translational Medicine. The National Cancer Institute (NCI) Center for Cancer Research (CCR) is co-hosting the event.Air date: 7/19/2019 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - May 20, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Scott J. Antonia, MD, PhD - Addressing Unmet Needs in Earlier Stages of NSCLC With Immunotherapy: Cutting-Edge Research, Clinical Applications, and Practical Challenges
In this activity, experts in the management of patients with non–small cell lung cancer (NSCLC) discuss the new standard of care for stage III locally advanced unresectable NSCLC following the recent approval of checkpoint inhibitor therapy for patients who have not progressed following chemoradiation therapy. In addition, the faculty consider how immunotherapy should be integrated into the management of patients with stage III NSCLC, the practical nuances of use, including timing and duration of therapy, as well as management of overlapping and nonoverlapping adverse effects, and immunotherapy-based rational treatme...
Source: Peerview CME/CE Video Podcast - Internal Medicine International - May 17, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

NCI Board of Scientific Advisors (BSA) and National Cancer Advisory Board (NCAB) Joint Meeting - June 2019
The 13th Joint Meeting of the NCI Board of Scientific Advisors and the National Cancer Advisory Board.Air date: 6/10/2019 8:30:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - May 13, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

' Sequence me': How genomic sequencing saved one patient's life
Bryce Olson, healthcare strategist at Intel, shares how he kicked cancer thanks to precision medicine and his work to empower cancer patients. (Source: Healthcare ITNews Videos)
Source: Healthcare ITNews Videos - May 6, 2019 Category: Information Technology Tags: HIMSS19 Patient Engagement Precision Medicine Source Type: video

Systems Biology Interest Group: Learning to rewire cells
Systems Biology Interest Group Traditionally, biology has focused on deconstructing and mapping the molecular systems that carryout complex regulatory functions. We still lack, however, a more global understanding of the design principles governing how cells solve problems and make regulatory decisions. To address this problem, we have been complementing deconstructionist approaches with synthetic approaches in which we ask how to build molecular systems that can execute particular regulatory tasks. Are there a limited number of molecular algorithms that evolution can use to solve common physiological tasks? If so, can we ...
Source: Videocast - All Events - May 1, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Clinical Implementation of Pharmacogenetic Testing
NCI ’ s Center for Cancer Research (CCR) Grand Rounds is a weekly lecture series addressing current research in clinical and molecular oncology. Speakers are leading national and international researchers and clinicians.Air date: 5/3/2019 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - May 1, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

CC Grand Rounds: Molecular Evolution of Prostate Cancer: Disease Development, Progression, and Drug Resistance
For more information go tohttps://www.cc.nih.gov/about/news/grcurrent.htmlAir date: 5/15/2019 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - April 29, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

The role of mass spectrometry to implement protein biomarkers in clinical studies for precision medicine
Proteomics Interest Group Understanding cancer biology at a molecular level has dramatically changed therapeutic strategies in oncology and improved patient care. As drugs become more targeted with clearer mode of actions, it is important to implement robust biomarkers into drug development process to precisely identify the right patients for clinical trials, to deliver safer and more effective drugs, and to reduce overall developmental costs. While genetic biomarkers are widely used, implementing protein biomarkers remains challenging in part due to the lack of robust technologies fit for clinical laboratories. Recently, ...
Source: Videocast - All Events - April 26, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Alpacas: More than just for sweaters -- a new medical advance.
Mini-antibodies found in the blood of camels, alpacas and llamas, shrunk further to create so-called "nanobodies," may help solve a problem in the cancer field: making specific types of T-cell therapies work in solid tumors. Scientists used these nanobodies -- which resemble antibodies in human ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - April 26, 2019 Category: Science Source Type: video

A community approach to breast cancer prevention: addressing health disparities
NIH Director's Wednesday Afternoon Lecture Series Dr. Adams-Campbell's areas of research focus on addressing health disparities with particular emphasis on cancers that disproportionately impact African-Americans. Dr. Adams-Campbell's research focuses on lifestyle interventions including physical activity, energy balance, obesity, metabolic syndrome, and oral health among minority and underserved populations. She has considerable expertise in cohort studies including the Women ’ s Health Initiative and the Black Women ’ s Health Study (which follows a cohort of African American women to gather epidemiological d...
Source: Videocast - All Events - April 24, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

2019 Demystifying Medicine Lecture- Autoimmunity: Basic and Clinical Advances and Challenges
Please join us for the next Demystifying Medicine lecture, " Autoimmunity: Basic and Clinical Advances and Challenges, " by Ronald Germain, M.D., Ph.D. (NIAID) and James Katz, M.D. (NIAMS) on April 23 from 4:00 p.m. to 5:30 p.m. in the Building 50 conference room, first floor. CME credit is available. Autoimmunity refers to a system of immune responses gone awry, tantamount to an attack against the body's own healthy cells and tissues with painful and often fatal consequences. This enemy within manifests itself in myriad ways, from targeted attacks (e.g., rheumatoid arthritis leading to debilitating joint damage...
Source: Videocast - All Events - April 19, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Mitchell S. Cairo, MD - Attacking the Clinical Problem of VOD/SOS in HCT Recipients: Insights on Pathophysiology, Diagnosis, and Treatment
In this activity, based on a live symposium held during the 2019 Transplantation and Cellular Therapy (TCT) Meetings of the American Society of Blood and Marrow Transplantation (ASBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR), experts in hematology-oncology explore new developments related to the changing clinical consensus for managing veno-occlusive disease (VOD)/sinusoidal obstruction syndrome (SOS) as a post-transplant complication. In this program, the panelists will share their views on VOD pathophysiology and proposed revisions to diagnostic and severity grading criteria, while ...
Source: Peerview CME/CE Video Podcast - Internal Medicine International - April 17, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

AAAS Martin and Rose Wachtel Cancer Research Award Ceremony
Special CCR Grand Rounds – 2019 AAAS Martin and Rose Wachtel Cancer Research Award and LectureAir date: 7/19/2019 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - April 12, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Annual Advances in Cancer Prevention Lecture
The Annual Advances in Cancer Prevention Lecture is sponsored by the Cancer Prevention Fellowship Program (CPFP) within the Division of Cancer Prevention (DCP) at NCI. It is also part of the course offerings of the annual NCI Summer Curriculum in Cancer Prevention, but is open to the entire NIH community and general public. This annual lecture addresses current challenges and/or approaches used by investigators to address gaps, advance science, and promote the application of successful strategies in the field of cancer prevention and control. This year's lecture will feature Scott M. Lippman, MD, Director of the...
Source: Videocast - All Events - April 11, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Summer Lecture Series II: Multidrug Resistance in Cancer
Multidrug Resistance in CancerFor more information go tohttps://www.training.nih.gov/events/view/_2/2685/Summer_Lecture_Series_II_Dr_Michael_GottesmanAir date: 7/30/2019 1:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - April 11, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

ORWH Women's Health Seminar Series: Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is a randomized breast screening trial that will help researchers learn about the best ways to find breast cancer in women who have no symptoms. It compares two Food and Drug Administration-approved types of digital mammography: standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D). Researchers are doing this trial because they do not know if 3-D mammography is better than 2-D mammography for breast cancer screening.For more information go tohttps://orwh.od.nih.gov/Air date: 6/20/2019 1:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - April 11, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

NINR Director's Lecture: Midlife Women ’ s Health: Using Technology to Enhance Research and Eliminate Disparities
2019 NINR Director's Lecture Dr. Eun-Ok Im will present " Midlife Women ’ s Health: Using Technology to Enhance Research and Eliminate Disparities " . In her presentation, Dr. Im will discuss her program of research, which uses computer and mobile technologies to eliminate gender and ethnic disparities. Eun-Ok Im, PhD, MPH, RN, CNS, FAAN is the Associate Dean for Research Development and Regulatory Affairs and Mary T. Champagne Professor at Duke University, School of Nursing. She has gained national and international recognition as a methodologist, researcher, and theorist in international, cross-cultural w...
Source: Videocast - All Events - April 9, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

2019 RNA Biology Symposium (Day 2)
RNA biology has emerged as one of the most influential areas in modern biology and biomedicine. The discovery of numerous new classes of RNAs and their function in a wide spectrum of biological processes has revolutionized molecular biology and has profound implications for clinical sciences. Key areas of current research include the elucidation of RNA biogenesis and structure, the identification of functions for various classes of RNAs, establishing the role of RNA in disease and the exploration of RNA-based-and RNA-targeted therapies. Organized by the CCR Initiative in RNA Biology, this symposium will bring together inte...
Source: Videocast - All Events - April 4, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

2019 RNA Biology Symposium (Day 1)
RNA biology has emerged as one of the most influential areas in modern biology and biomedicine. The discovery of numerous new classes of RNAs and their function in a wide spectrum of biological processes has revolutionized molecular biology and has profound implications for clinical sciences. Key areas of current research include the elucidation of RNA biogenesis and structure, the identification of functions for various classes of RNAs, establishing the role of RNA in disease and the exploration of RNA-based-and RNA-targeted therapies. Organized by the CCR Initiative in RNA Biology, this symposium will bring together inte...
Source: Videocast - All Events - April 4, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Arjun Balar, MD - Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes
Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - April 2, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Metabolomics-Based Discovery of Metabolic Aspects of Cancer and Other Diseases
ProtIG Seminar Dr. Anne Le ’ s research primarily focuses on cancer metabolism. Using metabolomics technologies, her work has led to breakthrough discoveries revealing several characteristic features of the metabolism of cancer. One of these, the dependence of cancer cells on glutamine metabolism, has translated into clinical trials as a novel therapy for cancer patients. In her talk, Dr. Le will discuss the complexity and diversity of cancer cell metabolism within the same tissue of origin, and even within individual tumor cell populations. Importantly, she will illustrate how to take advantage of metabolomics techn...
Source: Videocast - All Events - March 26, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

CC Grand Rounds: Building upon Cancer Immunotherapy by Understanding the Tumor Microenvironment
For more information go tohttp://www.cc.nih.gov/about/news/grcurrent.htmlAir date: 4/17/2019 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - March 20, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Translating Cancer Genomics to Clinical Care
NCI Center for Cancer Research Eminent Lecture Series Elaine Mardis, Ph.D., is co-Executive Director of the Institute for Genomic Medicine at Nationwide Children ’ s Hospital and the Nationwide Foundation Endowed Chair of Genomic Medicine. She also is Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Mardis joined Nationwide Children ’ s Hospital in 2016. Educated at the University of Oklahoma with a B.S. in Zoology and a Ph.D. in Chemistry and Biochemistry, Dr. Mardis did postgraduate work in industry at BioRad Laboratories. She was a member of the faculty of Washington University S...
Source: Videocast - All Events - March 20, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Neuro-Oncology NCI-CONNECT Annual Meeting Tumor Board - April 2019
Neuro-Oncology Tumor Board at the NCI-CONNECT Annual Meeting, April 29, 2019Air date: 4/29/2019 8:30:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - March 19, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Evan J. Lipson, MD - Urgent Care of Patients Receiving Cancer Immunotherapy: Recognition and Management of Immune-Mediated Adverse Reactions in the ED
Go online to PeerView.com/CBT860 to view the entire programme with slides. In this activity, experts in oncology and emergency medicine discuss principles of using immunotherapy to treat cancer, focusing specifically on the development of and recommendations for identifying, grading, and managing IMARs. Upon completion of this activity, participants will be able to: Describe the basic principles of harnessing the human immune system in the treatment of cancer, including the mechanistic aspects of immune checkpoint inhibition and development of immune-mediated adverse reactions (IMARs), Characterize the spectrum of IMARs: o...
Source: PeerView CME/CE Video Podcast - Oncology - March 12, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Evan J. Lipson, MD - Urgent Care of Patients Receiving Cancer Immunotherapy: Recognition and Management of Immune-Mediated Adverse Reactions in the ED
Go online to PeerView.com/CBT860 to view the entire program with slides. In this activity, experts in oncology and emergency medicine discuss principles of using immunotherapy to treat cancer, focusing specifically on the development of and recommendations for identifying, grading, and managing IMARs. Upon completion of this activity, participants will be able to: Describe the basic principles of harnessing the human immune system in the treatment of cancer, including the mechanistic aspects of immune checkpoint inhibition and development of immune-mediated adverse reactions (IMARs), Characterize the spectrum of IMARs: org...
Source: Peerview CME/CE Video Podcast - Internal Medicine International - March 12, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

ODP Early-Stage Investigator Lecture 2019 PM - Optimization of Physical Activity Promotion Interventions for Cancer Survivors
Our Early-Stage Investigator Lecture recognizes early-career prevention scientists who have not successfully competed for a substantial NIH-supported research project, but who have already made outstanding research contributions to their respective fields and are poised to become future leaders in prevention research. Dr. Phillips research uses technology and innovative study designs to better understand the determinants and outcomes of physical activity and the biopsychosocial mechanisms underlying the relationship between physical activity and health and disease outcomes. She has published over 70 articles in the areas o...
Source: Videocast - All Events - March 11, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Taking care to the next level: Start with the experience
Rebecca Kaul, Chief Innovation Officer at MD Anderson Cancer Center, discusses using technology to give your patients your best, rather than leading with innovative tech that doesn't always solve the big problems. (Source: Healthcare ITNews Videos)
Source: Healthcare ITNews Videos - March 11, 2019 Category: Information Technology Tags: Accountable Care HIMSS19 Patient Engagement Source Type: video

Richard S. Finn, MD - Breaking the Paradox: Expanding Options and New Questions in HCC Management —Mapping the Pathways to Better Patient Outcomes
Breaking the Paradox: Expanding Options and New Questions in HCC Management—Mapping the Pathways to Better Patient Outcomes (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - March 9, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Anna F. Farago, MD, PhD - The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy
The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - March 7, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Anna F. Farago, MD, PhD - The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy
The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - March 7, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Expanding the functional and actionable genome: Insights from the study of fusion-driven tumors
CCR Grand Rounds Dr. Caplen co-discovered RNA interference (RNAi) in mammalian cells and has pioneered approaches for exploiting this gene regulatory mechanism to investigate cancer biology and treatment. Dr. Caplen applies the perturbations induced by RNA- or DNA-based technologies to interrogate specific aspects of the genetic, transcriptional, and cell-signaling alterations observed in cancer cells. These functional genetic approaches will be used to enhance our understanding of the mechanistic basis of cancer and to discover new cancer treatment strategies. Current studies are focused on the functional genetic analysis...
Source: Videocast - All Events - March 4, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video

Kurt Schalper, MD, PhD and Edward B. Garon, MD, MS - Advances and Challenges in Refining the Use of Cancer Immunotherapies Through Biomarker Testing: Practical Guidance for Pathologists on the Front Lines of the Immuno-Oncology Revolution
Advances and Challenges in Refining the Use of Cancer Immunotherapies Through Biomarker Testing: Practical Guidance for Pathologists on the Front Lines of the Immuno-Oncology Revolution (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - March 4, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Anjali Saqi, MD, MBA and Geoffrey R. Oxnard, MD - Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - March 4, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video